Vaxcyte (PCVX) Enterprise Value (2020 - 2026)
Vaxcyte (PCVX) reported Enterprise Value of $6.93 billion for Q2 2026, up 170.8% from $2.56 billion a year earlier and up 4.2% from the prior quarter.
Powered by 
Analysis
Vaxcyte (PCVX) Enterprise Value (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Vaxcyte's Enterprise Value came in at $1.92 billion; for FY2025, it was $4.49 billion, down 47.1% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of 62.3% (FY2020 to FY2025).
- By year, Enterprise Value came in at $8.48 billion in FY2024 (+72.7%), $4.91 billion in FY2023 (+125.2%), $2.18 billion in FY2022 (+114.6%) and $1.02 billion in FY2021 (+154.7%).
- The Q2 2026 figure ranks as the highest quarterly Enterprise Value since Q4 2024.
- Year over year, Enterprise Value gained in four of the last eight quarters, with growth averaging 44.5%.
- The high point for year-over-year Enterprise Value in five years was Q2 2023 (growth of 268.9%); the low point was Q3 2025 (a decline of 75.3%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.65 billion (Q1 2026), $4.49 billion (Q4 2025) and $2.97 billion (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Vaxcyte | 8.44 Bn | 8.44 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6.93 Bn |
| Mar 31, 2026 | 6.65 Bn |
| Dec 31, 2025 | 4.49 Bn |
| Sep 30, 2025 | 2.97 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 3.20 Bn |
| Dec 31, 2024 | 8.48 Bn |
| Sep 30, 2024 | 12.04 Bn |
| Jun 30, 2024 | 6.90 Bn |
| Mar 31, 2024 | 5.94 Bn |
| Dec 31, 2023 | 4.91 Bn |
| Sep 30, 2023 | 3.58 Bn |
| Jun 30, 2023 | 3.40 Bn |
| Mar 31, 2023 | 2.20 Bn |
| Dec 31, 2022 | 2.18 Bn |
| Sep 30, 2022 | 1.09 Bn |
| Jun 30, 2022 | 921.17 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.02 Bn |
| Sep 30, 2021 | 1.06 Bn |
API Access
Vaxcyte Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=PCVX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "PCVX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=PCVX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();